The aim of this study was to compare three different awake tracheal intubation technique
-fiberoptic bronchoscopy (ATI:FB), videolaryngoscopy (ATI:VL), and fiberoptic bronchoscopy via a supraglottic airway device (ATI:SAD)- in terms of success rates, intubation times, and complications. Additionally, the study aims to evaluate the reliability of the SAD-assisted ATI method and its potential to contribute to the literature.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients aged 18 and older
* Patients classified as ASA I-II according to the American Society of Anesthesiologists (ASA) classification
* Patients scheduled for elective surgery
* Patients expected to require difficult mask ventilation, difficult laryngoscopy, or difficult tracheal intubation; patients expected to have short apnea periods (Planjuan goiter); patients at risk of aspiration; patients expected to require difficult rescue techniques; and patients with a reported history of difficult intubation
* Patients scheduled for intubation using the awake tracheal intubation (ATI) method
* Individuals who have agreed to participate in the study by signing an informed consent form
Exclusion Criteria:
* Patients with a mouth opening \<1.5 cm
* Patients requiring emergency intubation or emergency surgery (situations where there is insufficient time to administer ATI)
* Patients who cannot cooperate (mental incapacity, impaired consciousness, inability to communicate, etc.)
* Patients with known allergies to lidocaine or other local/topical anesthetic agents used
* Pregnancy
* Patients with a history of severe cardiac arrhythmia or hemodynamic instability (due to increased risk during intubation)
* Patients who have previously undergone tracheostomy or whose airway is technically obstructed due to anatomical deformity
* Patients who refuse to participate in the study or who do not provide informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Success rate of chosen awake intubation method
Timeframe: Through study completion, an average of 2 year